other

Updated:

Integra LifeSciences Holdings Corporation

Integra LifeSciences has a broad portfolio of innovative products and solutions used in neurosurgery, wound reconstruction and care, surgical reconstruction,...

Integra LifeSciences Holdings Corporation

Integra LifeSciences has a broad portfolio of innovative products and solutions used in neurosurgery, wound reconstruction and care, surgical reconstruction, surgical instrumentation and lighting, and ear, nose and throat.

General information

Firm type

public company

Year founded

1989

Location

Region

North America

Country

United States

City

Princeton

Corporate office

1100 Campus Road, Princeton, NJ 08540, United States

Additional offices

Añasco, Puerto Rico · Cordova, Tennessee

Principals

Jan Verstreken

President and Chief Executive Officer

Leigh J. Hough

Executive Vice President and Chief Financial Officer

Sector focus

Medical DevicesHealthcare ServicesSurgical Instruments

Frequently asked questions

Who runs investment decisions at Integra LifeSciences?

Investment decisions are made by the executive team led by CEO Jan Verstreken, who joined the company in 2022. Capital allocation is managed in-house, with acquisitions scouted and executed by the corporate development group.

How does Integra source new technologies?

Integra sources through a combination of internal R&D, direct acquisitions of companies and product lines, and licensing agreements. The company's business development team focuses on early-stage surgical and regenerative technologies (per the firm, 2026).

Is Integra structured as a family office or a public corporation?

Integra is a publicly traded corporation (Nasdaq: IART), not a family office. It has a board of directors elected by shareholders and reports quarterly earnings under SEC regulations.

What investment stages does Integra typically target?

Integra targets mature-stage companies with cleared or market-ready products. The company typically acquires established brands and technologies rather than early-stage startups, though it also invests in internal clinical trials for new indications.

Which sectors does Integra focus on?

Integra focuses on neurosurgery, wound reconstruction and care, surgical reconstruction, surgical instrumentation and lighting, and ear, nose and throat solutions. It avoids pharmaceuticals, diagnostics, and consumer health products.

Does Integra maintain philanthropic structures?

Yes, through the Integra Foundation, a charitable organization that supports brain tumor research, health equity, and community health initiatives. The foundation is separate from the for-profit operating company (per the firm).

What is Integra's known posture on co-investments?

Integra does not publicly participate in co-investment structures. Its acquisitions are funded from internal cash flow and debt financing, following standard public company capital allocation practices.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Princeton public company profiles